Literature DB >> 11475194

[Selective serotonin uptake inhibitors and pancreatitis].

K T Kvande1, S Madsen.   

Abstract

BACKGROUND: About 2% of all cases of pancreatitis are drug-induced. Several drugs cause pancreatitis, including selective serotonin reuptake inhibitors (SSRIs).
MATERIAL AND METHODS: Two Norwegian adverse drug event reports and a review of the international WHO adverse drug reactions database form the basis for this discussion. We found a total of 160 cases of pancreatitis associated with SSRIs.
RESULTS: Our findings support the notion that SSRIs may trigger pancreatitis in rare cases. The course of the disease may be severe and even fatal.
INTERPRETATION: Physicians should be aware of the possibility that SSRIs may trigger pancreatitis. Patients taking SSRIs should be evaluated for pancreatitis if they report abdominal pain of unknown cause.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475194

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  5 in total

1.  Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.

Authors:  Stefan Sevastru; Mai Wakatsuki; Jonathan Fennell; Michael P W Grocott
Journal:  BMJ Case Rep       Date:  2012-08-14

2.  Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-08-30       Impact factor: 2.953

Review 3.  Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  BMC Clin Pharmacol       Date:  2009-03-03

4.  Hyperamylasemia Related to Sertraline.

Authors:  Mehmet Emin Ceylan; Alper Evrensel; Barış Önen Ünsalver
Journal:  Korean J Fam Med       Date:  2016-07-21

5.  The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies.

Authors:  Shih-Wei Lai; Cheng-Chan Yu; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Dose Response       Date:  2020-03-30       Impact factor: 2.658

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.